![Foto de MARÍA](/img/nophoto.png)
MARÍA
CAMBRA PELLEJÀ
Forscher/in in der Zeit 2019-2022
Publikationen (11) Publikationen von MARÍA CAMBRA PELLEJÀ
2023
2022
-
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Gates Open Research, Vol. 6
-
Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control
The Lancet Infectious Diseases, Vol. 22, Núm. 11, pp. e341-e347
-
Novel compound shows in vivo anthelmintic activity in gerbils and sheep infected by Haemonchus contortus
Scientific Reports, Vol. 12, Núm. 1
-
Single-Nucleotide Polymorphisms in the Beta-Tubulin Gene and Its Relationship with Treatment Response to Albendazole in Human Soil-Transmitted Helminths in Southern Mozambique
American Journal of Tropical Medicine and Hygiene, Vol. 107, Núm. 3, pp. 649-657
2021
-
Control de las infecciones por nemátodos gastrointestinales
Tierras. Caprino, Núm. 34, pp. 38-42
-
Improving stool sample processing and pyrosequencing for quantifying benzimidazole resistance alleles in Trichuris trichiura and Necator americanus pooled eggs
Parasites and Vectors, Vol. 14, Núm. 1
-
La resistencia a los fármacos antihelmínticos: enfoque "One Health"
VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 25-26
-
Towards soil-transmitted helminths transmission interruption: The impact of diagnostic tools on infection prediction in a low intensity setting in Southern Mozambique
PLoS Neglected Tropical Diseases, Vol. 15, Núm. 10
2020
-
Teladorsagia circumcincta beta tubulin: the presence of the E198L polymorphism on its own is associated with benzimidazole resistance
Parasites & vectors, Vol. 13, Núm. 1, pp. 453
-
Zoonotic implications of onchocerca species on human health
Pathogens, Vol. 9, Núm. 9, pp. 1-17